ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals (OTCBB:RXHN), a biopharmaceutical company, dedicated to the discovery, development, and commercialization of innovative treatments for cancer and disorders of the central nervous system, was recently named “2006 Biotechnology Company of the Year” by the Monte Jade Science and Technology Association of Greater Washington D.C., during its “Evening of Celebration and Networking” held at the North Bethesda Marriott Hotel & Conference Center.
